deferoxamine has been researched along with Adult Rickets in 53 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aluminum-related osteomalacia has been a topic of major interest for some time." | 7.67 | Aluminum-related osteomalacia: clinical and histological improvement following treatment with desferrioxamine (DFO). ( Abulfil, A; Bab, I; Chaimovitz, C; Gazit, D; Mostovlavsky, M; Rapoport, J, 1987) |
| "The bone histology in patients with chronic renal failure and aluminum-related bone disease does not always show the excess accumulation of unmineralized osteoid (matrix) characteristic of osteomalacia." | 7.67 | Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy. ( Andress, DL; Coburn, JW; Endres, DB; Maloney, NA; Sherrard, DJ, 1987) |
| "Studies in patients on dialysis have shown that aluminum (Al) accumulation in bone plays a major role in the pathogenesis of osteomalacia." | 7.67 | The effects of discontinuation of aluminum exposure on aluminum-induced osteomalacia. ( Bergfeld, M; Chan, YL; Finch, JL; Martin, KJ; Slatopolsky, E; Teitelbaum, S, 1986) |
| "Three haemodialyzed chronic renal failure patients with histologically proven osteomalacia due to aluminium toxicity were treated with repeated injections of desferrioxamine, a potent chelator of aluminium." | 5.27 | [Desferrioxamine treatment of osteomalacia caused by aluminum poisoning]. ( Accominotti, M; Chapuy, MC; Charhon, SA; Chavassieux, P; Meunier, PJ; Traeger, J, 1986) |
| "Evidence has emerged over the last several years indicating that aluminum accumulation in patients with chronic renal failure can cause certain forms of renal osteodystrophy, in particular osteomalacia and an aplastic lesion." | 4.77 | Aluminum and renal osteodystrophy. ( Coburn, JW; Nebeker, HG, 1986) |
| "Aluminum-related osteomalacia has been a topic of major interest for some time." | 3.67 | Aluminum-related osteomalacia: clinical and histological improvement following treatment with desferrioxamine (DFO). ( Abulfil, A; Bab, I; Chaimovitz, C; Gazit, D; Mostovlavsky, M; Rapoport, J, 1987) |
| "The bone histology in patients with chronic renal failure and aluminum-related bone disease does not always show the excess accumulation of unmineralized osteoid (matrix) characteristic of osteomalacia." | 3.67 | Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy. ( Andress, DL; Coburn, JW; Endres, DB; Maloney, NA; Sherrard, DJ, 1987) |
| "Studies in patients on dialysis have shown that aluminum (Al) accumulation in bone plays a major role in the pathogenesis of osteomalacia." | 3.67 | The effects of discontinuation of aluminum exposure on aluminum-induced osteomalacia. ( Bergfeld, M; Chan, YL; Finch, JL; Martin, KJ; Slatopolsky, E; Teitelbaum, S, 1986) |
| "Aluminum-associated osteomalacia and transfusion-induced hemosiderosis developed in an anephric patient receiving long-term maintenance treatment with continuous ambulatory peritoneal dialysis." | 3.67 | Deferoxamine-enhanced fecal losses of aluminum and iron in a patient undergoing continuous ambulatory peritoneal dialysis. ( Kurtz, SB; McCarthy, JT; Mussman, GV, 1987) |
| "Desferrioxamine (DFO) was administered intravenously to a 63-year-old chronic hemodialysis patient with osteomalacia believed secondary to aluminum intoxication." | 3.67 | Thrombocytopenia associated with intravenous desferrioxamine. ( Eisinger, RP; Sherman, RA; Walker, JA, 1985) |
| " Twenty-four patients, 15 with dialysis osteomalacia and nine with clinically apparent secondary hyperparathyroidism, had serum aluminum levels measured before and after a standard infusion of a chelating agent, deferoxamine (DFO)." | 3.67 | Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine? ( Brown, P; Cordy, PE; Hodsman, AB; Hood, SA, 1985) |
| "2." | 2.66 | Deferoxamine-induced bone changes in haemodialysis patients: a histomorphometric study. ( Boivin, G; Chapuy, MC; Charhon, SA; Chavassieux, P; Meunier, PJ; Parisien, M; Traeger, J, 1987) |
| " Their prevention relies on adequate treatment of tapwater and definitive exclusion of long term administration of aluminum phosphate binders." | 2.41 | [Renal osteodystrophy (3); its treatment in dialysis patients]. ( Arsenescu, I; Benamar, L; el Esper, N; Fournier, A; Ghitu, S; Morinière, P; Oprisiu, R; Said, S; Tataru Albu, A, 2000) |
| " More frequent dosing and/or a longer duration of HP treatment might produce greater reversal of the Al-induced toxicity and perhaps reveal more adverse effects than seen in this study." | 1.30 | Short-term oral 3-hydroxypyridin-4-one dosing increases aluminum excretion and partially reverses aluminum-induced toxicity in the rabbit independent of chelator lipophilicity. ( Dickey, KM; Fredenburg, AM; Hong, CB; Meurer, KA; Skinner, TL; Yokel, RA, 1997) |
| " Oral ingestion of aluminium dosed 500 mg/day may result in significantly high plasma aluminium level." | 1.28 | [Detecting and evaluating hyperaluminemia in 3 dialysis centers]. ( Balabán, D; Kubátko, J; Simícková, J; Syrovátka, P, 1989) |
| "The deferoxamine (DFO) test has been advocated as a noninvasive procedure for the diagnosis of AI bone lesion." | 1.28 | Deferoxamine test and bone disease in dialysis patients with mild aluminum accumulation. ( Bielakoff, J; Chappuis, P; de Vernejoul, MC; Llach, F; London, G; Marchais, S; Morieux, C, 1989) |
| "Three haemodialyzed chronic renal failure patients with histologically proven osteomalacia due to aluminium toxicity were treated with repeated injections of desferrioxamine, a potent chelator of aluminium." | 1.27 | [Desferrioxamine treatment of osteomalacia caused by aluminum poisoning]. ( Accominotti, M; Chapuy, MC; Charhon, SA; Chavassieux, P; Meunier, PJ; Traeger, J, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 43 (81.13) | 18.7374 |
| 1990's | 8 (15.09) | 18.2507 |
| 2000's | 2 (3.77) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kashiwagi, T | 1 |
| Kurihara, S | 1 |
| Brown, DJ | 3 |
| Dawborn, JK | 3 |
| Ham, KN | 3 |
| Xipell, JM | 3 |
| Mudde, AH | 2 |
| Roodvoets, AP | 2 |
| Pierides, AM | 1 |
| Myli, MP | 1 |
| Hood, SA | 2 |
| Clark, WF | 1 |
| Hodsman, AB | 2 |
| Bolton, CF | 1 |
| Cordy, PE | 2 |
| Anderson, C | 1 |
| Leung, F | 1 |
| Ackrill, P | 1 |
| Day, JP | 1 |
| Jablonski, G | 1 |
| Klem, KH | 1 |
| Danielsen, CC | 1 |
| Mosekilde, L | 1 |
| Gordeladze, JO | 1 |
| Romero, RA | 2 |
| Salgado, O | 2 |
| Elejalde, LE | 1 |
| Rodríguez-Iturbe, B | 2 |
| Tahán, JE | 1 |
| Yokel, RA | 1 |
| Meurer, KA | 1 |
| Hong, CB | 1 |
| Dickey, KM | 1 |
| Skinner, TL | 1 |
| Fredenburg, AM | 1 |
| Ghitu, S | 1 |
| Oprisiu, R | 1 |
| Benamar, L | 1 |
| Said, S | 1 |
| Tataru Albu, A | 1 |
| Arsenescu, I | 1 |
| el Esper, N | 1 |
| Morinière, P | 2 |
| Fournier, A | 2 |
| Zanchetta, JR | 1 |
| Bogado, CE | 1 |
| Zuchini, A | 1 |
| Firmat, J | 1 |
| Ogura, Y | 1 |
| Yokoyama, K | 1 |
| Ohara, M | 1 |
| Navarro, JA | 1 |
| Granadillo, VA | 1 |
| García, R | 1 |
| Yamagata, K | 1 |
| Kobayashi, M | 1 |
| Koyama, A | 1 |
| Narita, M | 1 |
| Amagai, H | 1 |
| Ohno, A | 1 |
| Yoshikawa, S | 1 |
| Chan, MK | 1 |
| Varghese, Z | 1 |
| Li, MK | 1 |
| Wong, WS | 1 |
| Li, CS | 1 |
| Balabán, D | 1 |
| Simícková, J | 1 |
| Kubátko, J | 1 |
| Syrovátka, P | 1 |
| Chazan, JA | 1 |
| Abuelo, JG | 1 |
| Blonsky, SL | 1 |
| de Vernejoul, MC | 1 |
| Marchais, S | 1 |
| London, G | 1 |
| Bielakoff, J | 1 |
| Chappuis, P | 1 |
| Morieux, C | 1 |
| Llach, F | 2 |
| Felsenfeld, AJ | 1 |
| Rodriguez, M | 1 |
| Coleman, M | 1 |
| Ross, D | 1 |
| Mousson, C | 1 |
| Charhon, SA | 3 |
| Ammar, M | 1 |
| Accominotti, M | 2 |
| Rifle, G | 1 |
| Chavassieux, P | 2 |
| Chapuy, MC | 2 |
| Traeger, J | 2 |
| Meunier, PJ | 2 |
| Nebeker, HG | 4 |
| Coburn, JW | 6 |
| Norris, KC | 1 |
| O'Brien, AA | 1 |
| McParland, C | 1 |
| Keogh, JA | 1 |
| Boyce, BF | 1 |
| Mocan, MZ | 1 |
| Byars, J | 1 |
| Junor, BJ | 1 |
| Terao, N | 1 |
| Suzuki, M | 1 |
| Homma, S | 1 |
| Asano, Y | 1 |
| Hosoda, S | 1 |
| Furuse, M | 1 |
| Smetana, S | 1 |
| Popovtzer, MM | 1 |
| Bar-Khayim, Y | 1 |
| Rapoport, J | 1 |
| Chaimovitz, C | 1 |
| Abulfil, A | 1 |
| Mostovlavsky, M | 1 |
| Gazit, D | 1 |
| Bab, I | 1 |
| Milliner, DS | 3 |
| Hercz, G | 1 |
| Miller, JH | 1 |
| Shinaberger, JH | 1 |
| Nissenson, AR | 1 |
| Ott, SM | 2 |
| Andress, DL | 3 |
| Maloney, NA | 2 |
| Sherrard, DJ | 4 |
| Malluche, HH | 1 |
| Faugere, MC | 1 |
| Smith, AJ | 1 |
| Friedler, RM | 1 |
| Ihle, BU | 1 |
| Becker, GJ | 1 |
| Kincaid-Smith, PS | 1 |
| Alfrey, AC | 1 |
| Slatopolsky, EA | 1 |
| Slatopolsky, E | 2 |
| Espinoza, O | 1 |
| Gehrung, E | 1 |
| Roessler, E | 1 |
| Katz, E | 1 |
| Pérez, A | 1 |
| Delmastro, J | 1 |
| Endres, DB | 1 |
| Boivin, G | 1 |
| Parisien, M | 1 |
| Barré, PE | 1 |
| Prichard, S | 1 |
| Warady, BA | 1 |
| Ford, DM | 1 |
| Gaston, CE | 1 |
| Sedman, AB | 1 |
| Huffer, WE | 1 |
| Lum, GM | 1 |
| Finch, JL | 1 |
| Bergfeld, M | 1 |
| Martin, KJ | 1 |
| Chan, YL | 1 |
| Teitelbaum, S | 1 |
| McCarthy, JT | 2 |
| Kurtz, SB | 2 |
| Mussman, GV | 1 |
| Swartz, RD | 1 |
| Andreoli, SP | 1 |
| Dunn, D | 1 |
| DeMyer, W | 1 |
| Bergstein, JM | 1 |
| Van Groningen, K | 1 |
| McCall, JT | 1 |
| Fohrer, P | 1 |
| Leflon, P | 1 |
| Tolani, M | 1 |
| Lambrey, G | 1 |
| Demontis, R | 1 |
| Sebert, JL | 1 |
| Van Devyver, F | 1 |
| Debroe, M | 1 |
| Hess, T | 1 |
| Gautschi, K | 1 |
| Jungbluth, H | 1 |
| Binswanger, U | 1 |
| Botella, J | 1 |
| Gallego, JL | 1 |
| Fernandez-Fernandez, J | 1 |
| Sanz-Guajardo, D | 1 |
| de Miguel, A | 1 |
| Ramos, J | 1 |
| Franco, P | 1 |
| Enriques, R | 1 |
| Sanz-Moreno, C | 1 |
| Walker, JA | 1 |
| Sherman, RA | 1 |
| Eisinger, RP | 1 |
| Brown, P | 1 |
| Johnson, CI | 1 |
| Nelson, S | 1 |
| Tielemans, C | 1 |
| Collart, F | 1 |
| Wens, R | 1 |
| Smeyers-Verbeeke, J | 1 |
| van Hooff, I | 1 |
| Dratwa, M | 1 |
| Verbeelen, D | 1 |
5 reviews available for deferoxamine and Adult Rickets
| Article | Year |
|---|---|
[Aluminum and iron deposition in dialysis patients].
Topics: Aluminum; Aluminum Hydroxide; Anemia; Bone Diseases, Metabolic; Contraindications; Deferoxamine; Dem | 2004 |
[Renal osteodystrophy (3); its treatment in dialysis patients].
Topics: Aluminum; Calcium Carbonate; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Def | 2000 |
Aluminum and renal osteodystrophy.
Topics: 24,25-Dihydroxyvitamin D 3; Aluminum; Animals; Bone and Bones; Calcitriol; Caseins; Chronic Kidney D | 1986 |
Osteomalacia and bone disease arising from aluminum.
Topics: Aluminum; Animals; Bone and Bones; Bone Diseases; Deferoxamine; Humans; Kidney Failure, Chronic; Ost | 1986 |
Deferoxamine and aluminum removal.
Topics: Aluminum; Bone and Bones; Chelating Agents; Deferoxamine; Dementia; Humans; Iron; Osteomalacia; Peri | 1985 |
3 trials available for deferoxamine and Adult Rickets
| Article | Year |
|---|---|
Newcastle bone disease in Hong Kong: a study of aluminum associated osteomalacia.
Topics: Adult; Alkaline Phosphatase; Aluminum; Aluminum Hydroxide; Deferoxamine; Female; Fractures, Spontane | 1990 |
Clearance of aluminum by hemodialysis: effect of desferrioxamine.
Topics: Aluminum; Deferoxamine; Humans; Kidney Failure, Chronic; Osteomalacia; Renal Dialysis | 1986 |
Deferoxamine-induced bone changes in haemodialysis patients: a histomorphometric study.
Topics: Adult; Aluminum; Anthropometry; Bone and Bones; Deferoxamine; Female; Humans; Male; Middle Aged; Min | 1987 |
45 other studies available for deferoxamine and Adult Rickets
| Article | Year |
|---|---|
Treatment of dialysis osteomalacia with desferrioxamine.
Topics: Adult; Alkaline Phosphatase; Aluminum; Bone and Bones; Calcium; Deferoxamine; Electron Probe Microan | 1982 |
Desferrioxamine and osteomalacia.
Topics: Deferoxamine; Female; Humans; Middle Aged; Osteomalacia; Renal Dialysis | 1982 |
Therapy of aluminum overload (I).
Topics: Adult; Aged; Aluminum; Bone and Bones; Brain Diseases; Deferoxamine; Female; Humans; Kidney Failure, | 1984 |
Case report 294. Diagnosis: dialysis osteomalacia with response to desferrioxamine therapy.
Topics: Adult; Biopsy; Bone and Bones; Deferoxamine; Hand; Humans; Male; Osteomalacia; Radiography; Renal Di | 1984 |
Successful treatment of dialysis osteomalacia and dementia, using desferrioxamine infusions and oral 1-alpha hydroxycholecalciferol.
Topics: Aluminum; Biopsy; Bone and Bones; Deferoxamine; Dementia; Female; Glomerulonephritis; Hemodialysis, | 1984 |
Therapy of aluminium overload (II).
Topics: Aluminum; Brain Diseases; Deferoxamine; Humans; Kidney Failure, Chronic; Osteomalacia; Renal Dialysi | 1984 |
Aluminium-induced bone disease in uremic rats: effect of deferoxamine.
Topics: Adenylyl Cyclases; Aluminum; Animals; Biomechanical Phenomena; Bone and Bones; Bone Diseases; Bone R | 1996 |
Changes of metal concentrations in blood and peritoneal dialysate during long-term desferrioxamine B therapy.
Topics: Adult; Aluminum; Deferoxamine; Humans; Kidney Failure, Chronic; Male; Metals; Osteomalacia; Peritone | 1996 |
Short-term oral 3-hydroxypyridin-4-one dosing increases aluminum excretion and partially reverses aluminum-induced toxicity in the rabbit independent of chelator lipophilicity.
Topics: Administration, Oral; Aluminum Compounds; Anemia; Animals; Bile; Chelating Agents; Deferoxamine; Kid | 1997 |
[Bone mineral content and treatment with deferoxamine in patients under chronic hemodialysis].
Topics: Adult; Bone Density; Deferoxamine; Female; Humans; Male; Middle Aged; Osteomalacia; Renal Dialysis | 1992 |
[Dialysis encephalopathy].
Topics: Anticonvulsants; Apraxias; Deferoxamine; Dementia; Electroencephalography; Humans; Kidney Failure, C | 1992 |
Removal of trace metals by continuous ambulatory peritoneal dialysis after desferrioxamine B chelation therapy.
Topics: Adult; Aluminum; Chelation Therapy; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Osteomala | 1991 |
[A case of iron and aluminum related osteomalacia in a long-term hemodialysis patient].
Topics: Adult; Aluminum; Deferoxamine; Female; Ferritins; Humans; Infusions, Intravenous; Iron; Osteomalacia | 1991 |
[Detecting and evaluating hyperaluminemia in 3 dialysis centers].
Topics: Aluminum; Deferoxamine; Dialysis Solutions; Humans; Osteomalacia; Renal Dialysis | 1989 |
Plasma aluminum levels (unstimulated and stimulated): clinical and biochemical findings in 185 patients undergoing chronic hemodialysis for 4 to 95 months.
Topics: Aluminum; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Osteomalacia; Re | 1989 |
Deferoxamine test and bone disease in dialysis patients with mild aluminum accumulation.
Topics: Aluminum; Biopsy; Bone and Bones; Deferoxamine; Dialysis; Humans; Osteomalacia; Prospective Studies; | 1989 |
Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease.
Topics: Aluminum; Bone and Bones; Bone Diseases; Calcium; Deferoxamine; Diabetic Nephropathies; Female; Huma | 1989 |
Aluminium bone deposits in normal renal function patients after long-term treatment by plasma exchange.
Topics: Aged; Aluminum; Biopsy; Bone and Bones; Deferoxamine; Female; Humans; Kidney; Middle Aged; Osteomala | 1989 |
[Desferrioxamine treatment of osteomalacia caused by aluminum poisoning].
Topics: Adult; Aluminum; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Osteomala | 1986 |
The use of intravenous and intraperitoneal desferrioxamine in aluminium osteomalacia.
Topics: Adult; Aluminum; Deferoxamine; Humans; Injections, Intraperitoneal; Injections, Intravenous; Male; O | 1987 |
Treatment and histological healing of aluminum-related osteomalacia.
Topics: Adult; Aluminum; Calcium; Deferoxamine; Female; Hemodialysis Solutions; Humans; Hyperparathyroidism, | 1988 |
Rapid conversion from aluminium bone disease to hyperparathyroid bone disease by desferrioxamine.
Topics: Adult; Aluminum; Bone Diseases; Deferoxamine; Female; Fractures, Spontaneous; Humans; Hyperparathyro | 1988 |
[Aluminum-induced osteomalacia in chronic hemodialysis].
Topics: Aluminum; Child, Preschool; Deferoxamine; Female; Humans; Osteomalacia; Parathyroid Glands; Postoper | 1987 |
Aluminum-related osteomalacia: clinical and histological improvement following treatment with desferrioxamine (DFO).
Topics: Adult; Aluminum; Biopsy; Bone and Bones; Deferoxamine; Humans; Male; Osteomalacia; Renal Dialysis | 1987 |
Changes in bone histology after treatment with desferrioxamine.
Topics: Adolescent; Adult; Aluminum; Bone and Bones; Deferoxamine; Humans; Kidney Failure, Chronic; Male; Mi | 1986 |
Aluminum intoxication of bone in renal failure--fact or fiction?
Topics: Aluminum; Deferoxamine; Humans; Kidney Failure, Chronic; Osteomalacia; Renal Dialysis | 1986 |
Clinical and biochemical features of aluminum-related bone disease.
Topics: Adolescent; Adult; Aged; Aluminum; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Male; Midd | 1986 |
Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH.
Topics: Aluminum; Deferoxamine; Humans; Kidney Failure, Chronic; Osteomalacia; Parathyroid Hormone; Renal Di | 1986 |
The interaction of parathyroid hormone and aluminum in renal osteodystrophy.
Topics: Adult; Aluminum; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; | 1987 |
[Osteomalacia induced by aluminum in a patient under chronic hemodialysis: successful treatment with desferrioxamine].
Topics: Adult; Aluminum; Deferoxamine; Female; Humans; Osteomalacia; Renal Dialysis | 1986 |
Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy.
Topics: Adult; Aluminum; Bone Diseases, Metabolic; Deferoxamine; Female; Humans; Male; Middle Aged; Osteomal | 1987 |
Combined hemofiltration and desferrioxamine treatment for aluminum induced osteomalacia.
Topics: Aluminum; Blood; Deferoxamine; Humans; Male; Middle Aged; Osteomalacia; Renal Dialysis; Ultrafiltrat | 1986 |
Aluminum intoxication in a child: treatment with intraperitoneal desferrioxamine.
Topics: Aluminum; Anemia, Hypochromic; Chelating Agents; Deferoxamine; Humans; Infant; Kidney Failure, Chron | 1986 |
The effects of discontinuation of aluminum exposure on aluminum-induced osteomalacia.
Topics: Aluminum; Aluminum Chloride; Aluminum Compounds; Animals; Bone and Bones; Chlorides; Deferoxamine; D | 1986 |
Deferoxamine-enhanced fecal losses of aluminum and iron in a patient undergoing continuous ambulatory peritoneal dialysis.
Topics: Adult; Aluminum; Deferoxamine; Feces; Female; Hemosiderosis; Humans; Iron; Iron Deficiencies; Osteom | 1987 |
Intraperitoneal deferoxamine therapy for aluminum intoxication in a child undergoing continuous ambulatory peritoneal dialysis.
Topics: Aluminum; Anemia; Child; Deferoxamine; Epilepsies, Myoclonic; Humans; Kidney Failure, Chronic; Male; | 1985 |
Hypercalcaemic osteomalacia and encephalopathy due to aluminium intoxication in haemodialysis patients. Clinical aspects and treatment with desferrioxamine.
Topics: Aluminum Hydroxide; Brain Diseases; Deferoxamine; Female; Humans; Hypercalcemia; Male; Middle Aged; | 1985 |
Elevated bone aluminum content in dialysis patients without osteomalacia.
Topics: Adult; Aluminum; Biopsy; Bone and Bones; Deferoxamine; Glomerulonephritis; Histocytochemistry; Human | 1985 |
The desferrioxamine test predicts bone aluminium burden induced by A1(OH)3 in uraemic patients but not mild histological osteomalacia.
Topics: Aged; Aluminum; Aluminum Hydroxide; Bone and Bones; Deferoxamine; Female; Humans; Male; Middle Aged; | 1985 |
Incorporation of aluminium and effect of removal in experimental osteomalacia and fibro-osteoclasia.
Topics: Aluminum; Animals; Bone Resorption; Deferoxamine; Osteomalacia; Rats | 1985 |
The bone scan in patients with aluminium-associated bone disease.
Topics: Aluminum; Deferoxamine; Humans; Hyperparathyroidism, Secondary; Osteomalacia; Radionuclide Imaging; | 1985 |
Thrombocytopenia associated with intravenous desferrioxamine.
Topics: Aluminum; Deferoxamine; Humans; Hypotension; Injections, Intravenous; Kidney Failure, Chronic; Male; | 1985 |
Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine?
Topics: Adult; Aluminum; Biopsy; Bone and Bones; Deferoxamine; Dementia; Humans; Hyperparathyroidism, Second | 1985 |
Dialysis osteomalacia: a possible role for zirconium as well as aluminium.
Topics: Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Glomerulonephritis; Humans; Osteomal | 1985 |
Improvement of anemia with deferoxamine in hemodialysis patients with aluminum-induced bone disease.
Topics: Adult; Aluminum; Anemia, Hemolytic; Blood Transfusion; Deferoxamine; Female; Hematocrit; Humans; Mal | 1985 |